Administration Methods BPC-157 is typically administered via subcutaneous injections, where the peptide is injected into the fatty tissue just under the skin
In the state of energy surplus, the expansion of adipose tissue can occur through two primary mechanisms: adipocyte hyperplasia and hypertrophy [2, 3]
Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial Retatrutide, Eli Lillys next generation of weight loss injections, showed dramatic results in clinical trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight
For the low physical activity criteria, there were no changes in the L-carnitine group, while in the placebo group one subject (4.1%) changed from being mild to a moderately active status in terms of physical activity